Here are the most interesting things we saw in women's health this week:
🩺 During confirmation hearings, Trump's FDA nominee twice refused to say whether an IUD is just birth control (it is) or confirm that mifepristone is safe and effective. She inherits the agency's abortion pill review with a court deadline of October 7.
💊 More than 22,000 women ages 55-69 might have lived longer if they'd been prescribed vaginal estrogen for recurring UTIs, per a USA TODAY analysis. The FDA only removed its black box warning on the drug in November 2025.
🧬 Just 25% of U.S. women say they understand their menopause treatment options. And 37% say they first learned about menopause when they started having symptoms themselves, while 40% say it negatively affected their life or work.
TOP CLICKED STORIES THIS WEEK
Exclusive: FDA warnings persisted as UTIs turned deadly in menopause // USA TODAY
Lindsay Clancy case could spur legislative action on postpartum depression, psychosis // Stateline
Women's Experiences Accessing Health Information Online: Trusted Sources and Contraceptive Information // KFF
Many Women Enter Menopause Without Clear Information // Gallup
SWHR Statement on Reported Move to Establish Review Board for NIH Grants // SWHR
How abortion drug restrictions make it harder to treat other conditions // PBS NewsHour